Opinion of the Scientific Panel on Dietetic products, nutrition and allergies [NDA] related to two scientific publications concerning aspects of serum levels of phytosterols

EFSA Journal

Volumn 3, Issue 6, 2005, Pages

[No Author Info available]

Author keywords

cholesterol; coronary heart disease; lipid lowering medication; phytosterolaemia; Phytosterols

Indexed keywords

EID: 85078393896     PISSN: None     EISSN: 18314732     Source Type: Journal    
DOI: 10.2903/j.efsa.2005.211     Document Type: Article

References (5)

1. Miettinen TA, Strandberg TE, Gylling H (2000). Noncholesterol sterols and cholesterol-lowering by long-term Simvastatin treatment in coronary patients. Arterioscler Thromb Vasc Biol 20: 1340–1346.
2. Neil HA, Meijer GW, Roe LS (2001). Randomised controlled trial of use by hypercholesterolaemic patients of a vegetable oil sterol-enriched fat spread. Atherosclerosis 156: 329–337.
3. Nigon F, Serfaty-Lacrosniere C, Beucler I, Chauvois D, Neven C, Giral P, Chapman MJ, Bruckert E (2001). Plant sterol-enriched margarine lowers plasma LDL in hyperlipidemic subjects with low cholesterol intake: effect of fibrate treatment. Clin Chem Lab Med 39: 634–640.
4. SCF (Scientific Committee on Food) (2002). General view of the Scientific Committee on Food on the long-term effects of the intake of elevated levels of phytosterols from multiple dietary sources, with particular attention to the effects on β-carotene. Opinion adopted on 26 September 2002. europa.eu.int/comm/food/fs/sc/scf/out143_en.pdf
5. Sudhop T, Gottwald BM, von Bergmann K (2002). Serum plant sterols as a potential risk factor for coronary heart disease (a preliminary report). Metabolism 51: 1519–1521.